News
![Moon_pixabay_Likas_Bieri](https://pharmaphorum.com/wp-content/uploads/2022/04/Moon_pixabay_Likas_Bieri.jpg)
Jazz adds first immuno-oncology drug via $1.3bn Werewolf dea...
Jazz Pharma has bolstered its pipeline of cancer drugs through a $1.3 billion licensing agreement with Werewolf Therapeutics that adds its first immuno-oncology candidate.